Discordance of chronic rhinosinusitis disease control between EPOS guidelines and patient perspectives identifies utility of patient-rated control assessment

医学 一致性 慢性鼻-鼻窦炎 鼻息肉 可视模拟标度 疾病 内窥镜检查 物理疗法 疾病控制 外科 内科学 病毒学
作者
Ahmad R. Sedaghat,Kyle Singerman,Katie M. Phillips
出处
期刊:Rhinology [European Rhinologic Society]
被引量:8
标识
DOI:10.4193/rhin22.160
摘要

The objective of this study was to determine concordance of patient-reported chronic rhinosinusitis (CRS) disease control with CRS disease control assessed according to European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) criteria.In 421 participants, CRS disease control was determined using EPOS criteria which include the burden of 5 symptoms measured on a binary scale, use of rescue medications in the prior 6 months and presence of diseased mucosa on nasal endoscopy. Symptom severity was also assessed using a visual analogue scale (VAS). Participants rated their CRS disease control as "controlled","partly controlled" or "uncontrolled".Patient-reported and EPOS-based CRS disease control ratings agreed for 49.6% of participants. Amongst cases of disagreement, EPOS guidelines assessed worse CRS disease control relative to 92.9% of patients. Facial pain/pressure and impaired sense of smell distinctly associated with patient agreement with EPOS guidelines on having "uncontrolled" CRS. Higher VAS symptom scores were associated with worse patient-reported CRS disease control (i.e., agreeing with EPOS guidelines). Removal of the nasal endoscopy criterion improved agreement between patients' and EPOS control assessments, and replacement of this criterion with patient-reported control further aligned EPOS guidelines with patient perspectives.EPOS guidelines regularly assess worse CRS control than assessed by patients. The lack of more gradated symptom severity criteria and inclusion of nasal endoscopy may contribute to discordance of EPOS guidelines with patient-reported CRS control. Replacement of nasal endoscopy findings with a measure of patient-reported CRS disease control better aligns EPOS CRS disease control guidelines with patients' perspectives.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
万历完成签到,获得积分10
刚刚
朱心怡完成签到,获得积分10
刚刚
小蘑菇应助阳佟听荷采纳,获得10
刚刚
刚刚
独狼完成签到 ,获得积分10
1秒前
1秒前
wxiao发布了新的文献求助10
2秒前
朱晖发布了新的文献求助10
2秒前
2秒前
无糖乐完成签到,获得积分20
3秒前
kma发布了新的文献求助10
5秒前
无糖乐发布了新的文献求助10
5秒前
量子星尘发布了新的文献求助10
6秒前
6秒前
yoyo完成签到,获得积分10
7秒前
亦犹未进完成签到,获得积分10
7秒前
wangxiaobin完成签到 ,获得积分10
8秒前
平淡凡柔发布了新的文献求助10
8秒前
9秒前
wxiao完成签到,获得积分10
10秒前
CHEN__02_发布了新的文献求助10
10秒前
英姑应助无糖乐采纳,获得10
11秒前
学习使我快乐1917完成签到,获得积分10
12秒前
llly发布了新的文献求助10
12秒前
13秒前
无花果应助Amai采纳,获得30
13秒前
huoyan2006应助平淡凡柔采纳,获得10
14秒前
15秒前
16秒前
Obsession发布了新的文献求助10
18秒前
junxing完成签到,获得积分10
20秒前
CHEN__02_完成签到,获得积分10
21秒前
852应助燕燕于飞采纳,获得10
21秒前
刘一三完成签到 ,获得积分10
22秒前
万能图书馆应助guozizi采纳,获得10
22秒前
xiaoting应助友好凡霜采纳,获得30
23秒前
奋斗慕凝完成签到 ,获得积分10
23秒前
23秒前
Ava应助Wl0115采纳,获得10
23秒前
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969628
求助须知:如何正确求助?哪些是违规求助? 3514448
关于积分的说明 11174217
捐赠科研通 3249822
什么是DOI,文献DOI怎么找? 1795000
邀请新用户注册赠送积分活动 875537
科研通“疑难数据库(出版商)”最低求助积分说明 804856